Investors Contact Careers Research Request

Interpace Biosciences, Inc.

  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
    • Overview
    • Biomarkers Solutions
    • Genomics Services/Molecular Dx
    • Anatomic Path, Flow, and Cytogenetics
    • Integrated Biorepository
    • Bioinformatics Solutions
  • Patients
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Biosciences Enters into Agreement for $20 Million Investment from 1315 Capital and Ampersand Capital Partners

Jan 13, 2020

Interpace Biosciences Announces Collaborative Study with University of North Carolina to Assess the Use BarreGEN® after Ablation of Dysplastic Barrett’s Esophagus

Jan 6, 2020

Interpace Biosciences Announces New Draft LCD and Reimbursement for Its Proprietary Thyroid Assay, ThyGeNEXT®

Dec 17, 2019

Interpace Biosciences Expands Strategic Partnership Activities with Genecast Biotechnology in China

Dec 5, 2019

Interpace Biosciences Launches New Corporate Website

Dec 2, 2019

Interpace Diagnostics Changes Name to Interpace Biosciences; Announces Plans for Next Phase of Growth and Third Quarter 2019 Financial Results

Nov 13, 2019

Interpace to Host Conference Call and Webcast to Discuss Third Quarter 2019 Financial Results on Wednesday, November 13, 2019

Nov 12, 2019

Interpace Diagnostics Announces Publication of New Data on Thyroid Test Utility

Nov 4, 2019

Interpace to Present Data at the ATA Annual Meeting

Oct 29, 2019

Interpace to Present at the American College of Gastroenterology Conference

Oct 24, 2019
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • ...19
    © 2021 Interpace Biosciences, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    • Twitter
    • Facebook
    • Linkedin